These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Stem cells: promises versus limitations. Choumerianou DM; Dimitriou H; Kalmanti M Tissue Eng Part B Rev; 2008 Mar; 14(1):53-60. PubMed ID: 18454634 [TBL] [Abstract][Full Text] [Related]
26. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. Majka SM; Jackson KA; Kienstra KA; Majesky MW; Goodell MA; Hirschi KK J Clin Invest; 2003 Jan; 111(1):71-9. PubMed ID: 12511590 [TBL] [Abstract][Full Text] [Related]
27. Cell therapy to improve regeneration of skeletal muscle injuries. Qazi TH; Duda GN; Ort MJ; Perka C; Geissler S; Winkler T J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):501-516. PubMed ID: 30843380 [TBL] [Abstract][Full Text] [Related]
28. Advances in Stem Cell and Cell-Based Gene Therapy Approaches for Experimental Acute Lung Injury: A Review of Preclinical Studies. Mei SH; Dos Santos CC; Stewart DJ Hum Gene Ther; 2016 Oct; 27(10):802-812. PubMed ID: 27531647 [TBL] [Abstract][Full Text] [Related]
29. A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications. Cislo-Pakuluk A; Marycz K Stem Cell Rev Rep; 2017 Oct; 13(5):598-602. PubMed ID: 28643176 [TBL] [Abstract][Full Text] [Related]
30. Contemplating the bright future of stem cell therapy for cardiovascular disease. Sánchez PL; San Román JA; Villa A; Fernández ME; Fernández-Avilés F Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S138-51. PubMed ID: 16501622 [TBL] [Abstract][Full Text] [Related]
31. Concise review: Preclinical studies on human cell-based therapy in rodent ischemic stroke models: where are we now after a decade? Leong WK; Lewis MD; Koblar SA Stem Cells; 2013 Jun; 31(6):1040-3. PubMed ID: 23390084 [TBL] [Abstract][Full Text] [Related]
32. Cardiac cell-based therapy: cell types and mechanisms of actions. Ramos GA; Hare JM Cell Transplant; 2007; 16(9):951-61. PubMed ID: 18293894 [TBL] [Abstract][Full Text] [Related]
33. Stem cells for heart cell therapies. Jing D; Parikh A; Canty JM; Tzanakakis ES Tissue Eng Part B Rev; 2008 Dec; 14(4):393-406. PubMed ID: 18821841 [TBL] [Abstract][Full Text] [Related]
34. Smooth muscle progenitor cells: friend or foe in vascular disease? van Oostrom O; Fledderus JO; de Kleijn D; Pasterkamp G; Verhaar MC Curr Stem Cell Res Ther; 2009 May; 4(2):131-40. PubMed ID: 19442197 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow cell therapy in clinical trials: a review of the literature. Kim PJ; Yang PC Rev Recent Clin Trials; 2012 Aug; 7(3):204-13. PubMed ID: 22540909 [TBL] [Abstract][Full Text] [Related]
36. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Ratajczak MZ; Majka M; Kucia M; Drukala J; Pietrzkowski Z; Peiper S; Janowska-Wieczorek A Stem Cells; 2003; 21(3):363-71. PubMed ID: 12743331 [TBL] [Abstract][Full Text] [Related]
37. [Endothelial progenitor cells: new biomarkers and potential therapy in intensive care]. Seguin T; Braun T; Mira JP Med Mal Infect; 2007 Jun; 37(6):305-11. PubMed ID: 17512151 [TBL] [Abstract][Full Text] [Related]